Blogg

  • Reset
8.21.23 | Autoimmune
2023 Michigan Life Sciences Showcase

The MichBio Showcase will bring together industry professionals, thought leaders, and changemakers from all life sciences sectors with patients and […]

Medical professional woman smiling 5.8.23 | Women's Health Perspective
Layla Lohmann’s Graves’ Disease Journey

Twenty-six years ago, I was diagnosed with Graves’ disease with exophthalmos. Prior to this autoimmune disease diagnosis, I was always struggling with breathing issues and asthma.

5.7.23 | Health Equity
SWHR Adds Lupus to the Women’s Health Equity Initiative 

To bring attention to these disparities and help support individuals impacted by lupus, SWHR added lupus to the Women’s Health Equity Initiative campaign this May, in recognition of Lupus Awareness Month.

5.3.23 | Lupus
Examining Lupus Health Disparities for Lupus Awareness Month  

This Lupus Awareness Month, SWHR is reflecting on the need for urgent action to close the gender, race, and ethnic disparities in lupus outcomes.

3.31.23 | Autoimmune
Final Policy Brief of Four-Part Series Shines Light on Need for Diversity Within Autoimmune Clinical Trials

Recognizing the significant impact that diversity has on the nation's ability to improve autoimmune outcomes and advance health equity, SWHR developed the policy brief, “The Need for Diversity in Autoimmune Disease Research Trials.”

3.31.23 | Autoimmune
Third Policy Brief Highlights Role of Federal Agencies in Supporting Women with Autoimmune Diseases and Conditions

The SWHR policy brief, “Federal Agencies’ Work in Autoimmune Diseases and Conditions,” demonstrates how federal agencies are contributing to improved health and health care for women across the lifespan and why investments in these programs and initiatives should continue to be prioritized.

3.31.23 | Autoimmune
Federal Agencies’ Work in Autoimmune Diseases and Conditions

The U.S. government—through its programs and initiatives—has an important role to play in improving the lives of those living with […]

3.31.23 | Autoimmune
The Need for Diversity in Autoimmune Disease Research Trials

While the United States has made progress to close the gaps that have resulted from the historical exclusion of women […]

3.30.23 | Autoimmune
Diversity in Autoimmune Clinical Trials: Addressing Areas of Need and Opportunity

3.22.23 | Autoimmune
Diversity in Autoimmune Clinical Trials: Addressing Areas of Need and Opportunity

During this SWHR Instagram Live event, hear from experts about why clinical trial representation is critical for improving outcomes, where they see the greatest issues in clinical trial representation, and if federal proposals to rectify underrepresentation of certain populations could improve involvement.